Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 118Neoplasms 110Lung Neoplasms 65Colorectal Neoplasms 52Prostatic Neoplasms 46Carcinoma, Non-Small-Cell Lung 46Pancreatic Neoplasms 34Melanoma 33Ovarian Neoplasms 29Neoplastic Cells, Circulating 29Head and Neck Neoplasms 27Uterine Cervical Neoplasms 23Multiple Myeloma 20Glioma 20Colonic Neoplasms 20Carcinoma, Hepatocellular 20Sarcoma 19Leukemia, Myeloid, Acute 18Neoplasm Metastasis 17Lymphoma 15Glioblastoma 15Esophageal Neoplasms 15Squamous Cell Carcinoma of Head and Neck 14Hematologic Neoplasms 14Endometrial Neoplasms 14Leukemia 13Myelodysplastic Syndromes 11Kidney Neoplasms 11Gastrointestinal Neoplasms 11Carcinoma, Renal Cell 11

Interventions

Cyclophosphamide 16Etoposide 14Carboplatin 11Temozolomide 10Vincristine 9Granulocyte Colony-Stimulating Factor 9Filgrastim 9Magnetic Resonance Spectroscopy 8Cisplatin 8etoposide phosphate 7X-Rays 7Thiotepa 7Phantoms, Imaging 7Methotrexate 7tazemetostat 6Topotecan 6Specimen Handling 6Radiotherapy 6Stem Cell Transplantation 5Nuclear Medicine Department, Hospital 5fludarabine 4Peripheral Blood Stem Cell Transplantation 4Mesna 4Melphalan 4Biopsy 4palbociclib 3Sirolimus 3Nivolumab 3Leucovorin 3Irinotecan 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Rhabdoid Tumor × Blood Specimen Collection × Clear all
NCT07447076 2026-03-03

Study of Novel Therapies for Young People With Recurrent/Progressive Atypical Teratoid Rhabdoid Tumor (ATRT)

University of California, San Francisco

Phase 2 Not yet recruiting
29 enrolled

Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡